BACKGROUND Atherosclerosis, a major contributor to coronary artery disease (CAD), is characterized by chronic arterial inflammation. Pentraxin 3 (PTX-3), a biomarker of inflammation, serves as an indicator of both atherosclerosis and the progression of CAD. The aim of our study was to investigate the association between PTX-3 levels and the presence and severity of CAD, as determined by coronary computed tomography angiography (CCTA).
METHODS In the study, 94 participants (54 with CAD and 40 controls) underwent CCTA and coronary artery calcium scoring (CACS) using computed tomography, with PTX-3 levels measured by the ELISA method. CAD patients were categorized based on CCTA findings and further subdivided into three groups according to their CACS: Group I (<100), Group II (100–300), and Group III (≥300).
RESULTS Serum PTX-3 levels were significantly higher in the CAD group. A PTX3
cut-off value of 5.80 ng/mL predicted CAD with 68% sensitivity and 66% specificity.
There was a strong positive correlation between CACS and PTX3 levels (r = 0.521, p
< 0.001), particularly in high-risk patients with a CACS over 300, where PTX3 levels
were significantly higher than in low- and intermediate-risk groups with a CACS ≥
300. No significant difference in PTX3 levels was observed between the normal coronary group, low- and intermediate-risk groups, and no correlation was found between coronary artery stenosis degree and PTX3 levels.
CONCLUSION PTX-3 might serve as a valuable biomarker for the diagnosis and severity of CAD.
Copyright © 2025 Archives of the Turkish Society of Cardiology